5
Views
3
CrossRef citations to date
0
Altmetric
Original Article

A comparative in vitro study of amphotericin B, clotrimazole and 5-fluorocytosine against clinically isolated yeasts

Pages 276-283 | Published online: 09 Jul 2009

References

  • Bodenhoff Jessie. A new antimycotic from Bayer AG: BAY b 5097. Acta pathologica et microbiologica scandanavica 1971; 79: 345–348, B
  • Denny Maire J., Partridge Betty M. Tetrazolium medium as an aid in the routine diagnosis of Candida. Journal of Clinical Pathology 1968; 21: 383–386
  • Drouhet E. Some biological activities of antifungal antibiotics and their mode of action. Ciba Foundation Symposium on Systemic Mycoses 1968; 206–240
  • Fields B.T., Bates J.H., Abernathy R.S. Amphotericin B serum concentrations during therapy. Applied Microbiology 1970; 19: 955–959
  • Garrod L.P., O'Grady F. Antibiotic & Chemotherapy3rd edition. E. & S. Livingstone, London 1971; 236–241
  • Grunberg E., Titsworth E., Bennett N. Chemotherapeutic activity of 5-fluorocystosine. Antimicrobial Agents & Chemotherapy 1964; 566–568
  • Herrell W.E. The antifungal activity of 5-fluorocytosine. Clinical Medicine February, 1971; 78: 11–13
  • The Yeasts — a taxonomic study, J. Lodder. North-Holland, Amsterdam and London 1970
  • Marks M.I., Steer P., Eickhoff T.C. In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (BAY 5097). Applied Microbiology 1971; 22: 93–95
  • Marks M.I., Eickhoff T.C. Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Antimicrobial Agents & Chemotherapy. 1971; 491–493, 1970
  • Oberste-Lehn H., Baggesen I., Plempel M. Preliminary clinical studies of a new oral antimycotic agent in systemic mycosis. German Medical Monthly 1969; 14: 537–539
  • Plempel M., Bartmann K., Buchel K.H., Regel E. Experimental study of a new orally effective broad-spectrum antimycotic agent. German Medical Monthly 1969; 14: 532–537
  • Plempel M., Bartmann K., Buchel K.H., Regel E. BAY b 5097, a new orally applicable antifungal substance with broad-spectrum activity. Antimicrobial Agents & Chemotherapy. 1970; 271–274, 1969
  • Shadomy S. In vitro studies with 5-fluorocytosine. Applied Microbiology 1969; 17: 871–871
  • Shadomy S. Further in vitro studies with 5-fluorocytosine. Infection & Immunity 1970; 2: 484–488
  • Shadomy S. In vitro antifungal activity of clotrimazole (BAY b 5097). Infection & Immunity 1971; 4: 143–148
  • Utz J.P., Tynes B.S., Shadomy Helen J., Duma R.J., Kannan M.M., Mason K.N. 5-fluorocytosine in human cryptococcosis. Antimicrobial Agents & Chemotherapy 1969; 344–346, 1968

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.